RAP 0.00% 20.5¢ raptor resources limited

Ann: Further Positive Preliminary Results from Clinical Study, page-3

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 1,458 Posts.

    Further Positive Preliminary Results from Current Clinical Study

    High accuracy achieved for the diagnosis of additional respiratory diseases as well as the differential diagnosis of respiratory disease

    • 100% accuracy for distinguishing patients with bronchiolitis from subjects with no discernible respiratory disease

    • 99% accuracy for distinguishing patients with croup from subjects with no discernible respiratory disease

    • 96% accuracy (with the addition of existence of fever to the algorithm) for distinguishing patients with upper respiratory tract infection (URTI) from subjects with no discernible respiratory disease

    • 97% accuracy for distinguishing patients with viral pneumonia from subjects with no discernible respiratory disease on a larger dataset than previously reported

    • Successfully demonstrated differentiating patients with a particular respiratory disease from patients with other respiratory diseases with accuracy in the range of 89% to 99%
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.